Biotech Firm's Shares Plummet Amid Planned Pivot to Dogecoin Mining
Dogecoin mining is quite the shift for biotech firm Coeptis Therapeutics, and shareholders don't appear thrilled with the proposed move.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This mining story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Bitcoin (BTC) Price Today: $81.1K Becomes Critical as Traders Eye Double-Bottom Setup
Bitcoin recently climbed above $85,000 before encountering renewed selling pressure. Glassnode’s latest Week On-Chain report shows...
Gnosis bridges cut Ethereum deposit waits to seconds with fast confirmation
Gnosis' integration of FCR enhances transaction speed, potentially boosting user engagement and cross-chain activity, despite secu...
ESMA orders MiCA firms to halt services for non-compliant stablecoins
The EU's deadline for crypto firms to drop non-compliant stablecoins like USDT may reshape market dynamics and regulatory strategi...
ESMA gives crypto firms 3 months to exit non-compliant stablecoins
ESMA urged EU crypto firms to halt services involving non-MiCA-compliant stablecoins, giving regulators three months to address ex...
XRP Whales Dominate Exchange Outflows as Bitcoin Shorts Rise on Hyperliquid
The contrasting flows highlight a market where some large investors are moving XRP away from exchanges even as leveraged traders p...
Hyperliquid confirms Singapore base, but MAS says it is not the regulator
Hyperliquid's unregulated status in Singapore highlights the challenges and risks in the evolving decentralized finance landscape....